ID
17306
Description
Efficacy and Safety of Biphasic Insulin Aspart 30 in Subjects With Type 2 Diabetes; ODM derived from: https://clinicaltrials.gov/show/NCT00605111
Link
https://clinicaltrials.gov/show/NCT00605111
Keywords
Versions (1)
- 9/6/16 9/6/16 -
Uploaded on
September 6, 2016
DOI
To request one please log in.
License
Creative Commons BY 4.0
Model comments :
You can comment on the data model here. Via the speech bubbles at the itemgroups and items you can add comments to those specificially.
Itemgroup comments for :
Item comments for :
In order to download data models you must be logged in. Please log in or register for free.
Eligibility Diabetes NCT00605111
Eligibility Diabetes NCT00605111
- StudyEvent: Eligibility
Description
Exclusion Criteria
Alias
- UMLS CUI
- C0680251
Description
Diabetes Mellitus, Insulin-Dependent
Data type
boolean
Alias
- UMLS CUI [1]
- C0011854
Description
Investigational New Drugs
Data type
boolean
Alias
- UMLS CUI [1]
- C0013230
Description
Thiazolidinediones
Data type
boolean
Alias
- UMLS CUI [1]
- C1257987
Description
Oral hypoglycemic Quantity
Data type
boolean
Alias
- UMLS CUI [1,1]
- C0359086
- UMLS CUI [1,2]
- C1265611
Similar models
Eligibility Diabetes NCT00605111
- StudyEvent: Eligibility
C0872146 (UMLS CUI [1,2])
C0919936 (UMLS CUI [1,2])
C1265611 (UMLS CUI [1,2])
C0009429 (UMLS CUI [2])
C1265611 (UMLS CUI [1,2])